For many years, Sanger sequencing has been the default method for plasmid verification. It is familiar, targeted and reliable for short sequence checks. But plasmid validation is often more complicated than confirming one insert junction or mutation site.

When a construct contains a long insert, multiple engineered regions, repetitive sequence, uncertain assembly products or important backbone elements, targeted sequencing can leave gaps in confidence. Researchers may need to design additional primers, wait for primer synthesis, repeat failed reactions, perform primer walking or manually piece together partial sequence information.

With ONT-based whole plasmid sequencing now available as a fast, primer-free and cost-effective workflow, whole construct verification is no longer only a specialist option for complex plasmids. For many routine plasmid verification projects, sequencing the whole plasmid directly can be the simpler and more informative choice.

What Sanger sequencing does well

Sanger sequencing is widely used for targeted DNA sequence confirmation. In plasmid workflows, it is often used to check whether a cloned insert, mutation site or short engineered region matches the expected design.

For focused sequence checks, Sanger sequencing remains useful. If the target region is short, the expected sequence is known, and only one or two regions need to be checked, Sanger sequencing can provide a straightforward answer.

Sanger sequencing may be suitable when the region of interest is short, the target site is well defined, and the main question is whether a specific insert, mutation or junction is correct.

The key point is that Sanger sequencing answers a targeted question. It can confirm the sequence covered by the primer and read, but it does not necessarily confirm the rest of the plasmid.

Where targeted sequencing becomes less efficient

The practical challenge with Sanger sequencing is not only read length. It is also the workflow around it.

For larger or more complex plasmids, researchers may need to design multiple primers, order primers, repeat failed reads and perform primer walking to cover additional regions. Even then, the result may still be a patchwork of targeted reads rather than a complete view of the construct.

This matters because plasmid problems are not always located where the primer was placed. A correct insert read does not necessarily confirm that the backbone, orientation, regulatory elements or full construct structure are also correct.

The real cost of targeted plasmid checks is therefore not only the sequencing reaction itself. It can also include primer design time, primer synthesis, troubleshooting, manual alignment and the uncertainty of deciding whether unsequenced regions are acceptable.

What whole plasmid sequencing adds

Whole plasmid sequencing is designed to verify the entire plasmid rather than selected regions. Long-read sequencing is particularly useful for plasmid analysis because reads can span larger regions of the construct, supporting full-plasmid coverage and structural review.

Instead of asking only “Is this insert correct?”, whole plasmid sequencing supports broader questions. Is the insert present and in the expected orientation? Does the full plasmid match the expected design? Is the backbone intact? Are key elements such as promoters, tags and resistance markers present as expected? Are there unexpected deletions, insertions or rearrangements?

This can be especially valuable for expression vectors, CRISPR constructs, reporter plasmids, synthetic biology assemblies, multi-part cloning products and plasmids used before transfection or vector preparation.

A practical comparison

Sanger sequencing is best suited to targeted checks. It is useful when the region is short, the primer position is clear and the question is limited to a specific site or junction.

Whole plasmid sequencing is better suited to full construct verification. It can review the insert, backbone and wider plasmid structure in one workflow, without project-specific sequencing primers or routine primer walking.

This difference becomes important as plasmid size and complexity increase. With Sanger sequencing, the workflow burden can increase as more regions need to be covered. With whole plasmid sequencing, the aim is to move from partial confirmation to full-plasmid review.

When to choose each method

Sanger sequencing may still be enough when the question is narrow and easy to cover, such as confirming a short mutation site, a small insert, a single junction or a PCR-amplified region.

Whole plasmid sequencing is the stronger choice when the plasmid itself is the foundation of the downstream experiment. This includes expression vectors, CRISPR or reporter constructs, synthetic biology plasmids, long inserts, multi-step assemblies, or cases where Sanger results are incomplete or difficult to interpret.

In many cases, the practical comparison is no longer simply “cheap Sanger” versus “expensive whole plasmid sequencing”. The more useful question is whether it is more efficient to keep checking selected regions, or to sequence the whole construct directly.

Whole plasmid sequencing through Novogene Europe

Novogene Europe’s PlasmidGo service provides ONT-based whole plasmid sequencing for customer-provided plasmid DNA. The service is designed to support fast, primer-free plasmid verification, helping researchers assess sequence, structure and insert integrity without primer walking.

With online ordering, streamlined data delivery and sample collection options in selected locations, PlasmidGo is designed to make whole plasmid sequencing accessible for routine research workflows as well as more complex construct validation.

For researchers who are routinely verifying plasmids, the practical benefit is clear: whole plasmid sequencing can reduce primer design, repeated troubleshooting and partial interpretation, while providing a fuller view of the construct in one workflow.

Ready to check the whole construct? Explore Novogene Europe’s Whole Plasmid Sequencing service and start your online order.

References

1. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. PNAS. 1977.
2. Mumm C et al. Multiplexed long-read plasmid validation and analysis using OnRamp. Genome Research. 2023.
3. Emiliani FE, Hsu I, McKenna A. Multiplexed assembly and annotation of synthetic biology constructs using long-read nanopore sequencing. ACS Synthetic Biology. 2022.